中文名 | SJ-172550 |
英文名 | SJ-172550 |
别名 | 化合物SJ-172550 MDMX小分子抑制剂(SJ-172550) 2-(2-氯-6-乙氧基-4-((3-甲基-5-氧代-1-苯基-1H-吡唑-4(5H)-亚基)甲基)苯氧基)乙酸甲酯 |
英文别名 | CS-1226 SJ-172550 SJ 172550 MDMX Antagonist, SJ-172550 Methyl 2-(2-chloro-6-ethoxy-4-((3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)methyl)phenoxy)acetate 2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]aceticacidmethylester Acetic acid, 2-[2-chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-, methyl ester |
CAS | 431979-47-4 |
化学式 | C22H21ClN2O5 |
分子量 | 428.87 |
密度 | 1.27±0.1 g/cm3(Predicted) |
沸点 | 560.8±60.0 °C(Predicted) |
溶解度 | DMSO: ≥ 30 mg/mL |
酸度系数 | -0.30±0.40(Predicted) |
存储条件 | Sealed in dry,2-8°C |
外观 | 粉末 |
颜色 | orange |
体外研究 | The p53 pathway is disrupted in virtually every human tumor. SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. SJ-172550 binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor nutlin-3a. SJ-172550 acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates. |
危险品标志 | Xn - 有害物品 |
风险术语 | 22 - 吞食有害。 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.332 ml | 11.659 ml | 23.317 ml |
5 mM | 0.466 ml | 2.332 ml | 4.663 ml |
10 mM | 0.233 ml | 1.166 ml | 2.332 ml |
5 mM | 0.047 ml | 0.233 ml | 0.466 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!